Abstract
Malignant bone tumors affecting the brain and spine are a rare and exceedingly difficult-to-treat group of diseases. Most commonly consisting of chordoma and chondrosarcoma, these tumors also include giant-cell tumors and osteosarcomas. This chapter will cover the background, epidemiology, genetics, molecular biology, histopathology, radiographic features, clinical manifestations, therapeutic approaches, and clinical management of each entity.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abdallah HM, Gersey ZC, Muthiah N et al (2021) An integrated management paradigm for skull base chordoma based on clinical and molecular characteristics. J Neurol Surg B Skull Base 82:601–607. https://doi.org/10.1055/s-0041-1730958
Almefty KK, Pravdenkova S, Sawyer J, Al-Mefty O (2009) Impact of cytogenetic abnormalities on the management of skull base chordomas. J Neurosurg 110:715–724. https://doi.org/10.3171/2008.9.JNS08285
Amary F, Berisha F, Ye H et al (2017) H3F3A (Histone 3.3) G34W Immunohistochemistry: a reliable marker defining benign and malignant giant cell tumor of bone. Am J Surg Pathol 41:1059–1068. https://doi.org/10.1097/PAS.0000000000000859
Amit M, Na’ara S, Binenbaum Y et al (2014) Treatment and outcome of patients with skull base chordoma: a meta-analysis. J Neurol Surg B Skull Base 75:383–390. https://doi.org/10.1055/s-0034-1376197
Anninga JK, Gelderblom H, Fiocco M et al (2011) Chemotherapeutic adjuvant treatment for osteosarcoma: where do we stand? Eur J Cancer 47:2431–2445. https://doi.org/10.1016/j.ejca.2011.05.030
Arai M, Nobusawa S, Ikota H et al (2012) Frequent IDH1/2 mutations in intracranial chondrosarcoma: a possible diagnostic clue for its differentiation from chordoma. Brain Tumor Pathol 29:201–206. https://doi.org/10.1007/s10014-012-0085-1
Arshi A, Sharim J, Park DY et al (2017) Chondrosarcoma of the osseous spine: an analysis of epidemiology, patient outcomes, and prognostic factors using the SEER registry from 1973 to 2012. Spine (Phila Pa 1976) 42:644–652. https://doi.org/10.1097/BRS.0000000000001870
Bahr AL, Gayler BW (1977) Cranial chondrosarcomas. Report of four cases and review of the literature. Radiology 124:151–156. https://doi.org/10.1148/124.1.151
Bardakhchyan S, Kager L, Danielyan S et al (2017) Denosumab treatment for progressive skull base giant cell tumor of bone in a 14 year old female - a case report and literature review. Ital J Pediatr 43:32. https://doi.org/10.1186/s13052-017-0353-0
Barzilai O, Fisher CG, Bilsky MH (2018) State of the art treatment of spinal metastatic disease. Neurosurgery 82:757–769. https://doi.org/10.1093/neuros/nyx567
Behjati S, Tarpey PS, Presneau N et al (2013) Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone. Nat Genet 45:1479–1482. https://doi.org/10.1038/ng.2814
Biermann JS (2002) Common benign lesions of bone in children and adolescents. J Pediatr Orthop 22:268–273
Bloch O, Parsa AT (2013) Skull base chondrosarcoma: evidence-based treatment paradigms. Neurosurg Clin N Am 24:89–96. https://doi.org/10.1016/j.nec.2012.08.002
Bloch OG, Jian BJ, Yang I et al (2009) A systematic review of intracranial chondrosarcoma and survival. J Clin Neurosci 16:1547–1551. https://doi.org/10.1016/j.jocn.2009.05.003
Bloch OG, Jian BJ, Yang I et al (2010) Cranial chondrosarcoma and recurrence. Skull Base 20:149–156. https://doi.org/10.1055/s-0029-1246218
Bohman L-E, Koch M, Bailey RL et al (2014) Skull base chordoma and chondrosarcoma: influence of clinical and demographic factors on prognosis: a SEER analysis. World Neurosurg 82:806–814. https://doi.org/10.1016/j.wneu.2014.07.005
Boriani S, De Iure F, Bandiera S et al (2000) Chondrosarcoma of the mobile spine: report on 22 cases. Spine (Phila Pa 1976) 25:804–812. https://doi.org/10.1097/00007632-200004010-00008
Boriani S, Saravanja D, Yamada Y et al (2009) Challenges of local recurrence and cure in low grade malignant tumors of the spine. Spine (Phila Pa 1976) 34:S48–57. https://doi.org/10.1097/BRS.0b013e3181b969ac
Boriani S, Bandiera S, Casadei R et al (2012) Giant cell tumor of the mobile spine: a review of 49 cases. Spine (Phila Pa 1976) 37:E37–45. https://doi.org/10.1097/BRS.0b013e3182233ccd
Brackmann DE, Toh EH (2002) Surgical management of petrous apex cholesterol granulomas. Otol Neurotol 23:529–533. https://doi.org/10.1097/00129492-200207000-00023
Brackmann DE, Teufert KB (2006) Chondrosarcoma of the skull base: long-term follow-up. Otol Neurotol 27:981–991. https://doi.org/10.1097/01.mao.0000233812.48800.b4
Brown EW, Megerian CA, McKenna MJ, Weber A (1995) Fibrous dysplasia of the temporal bone: imaging findings. Am J Roentgenol 164:679–682. https://doi.org/10.2214/ajr.164.3.7863893
Campanacci M, Baldini N, Boriani S, Sudanese A (1987) Giant-cell tumor of bone. J Bone Joint Surg Am 69:106–114
Capodano A (2003) Bone: osteosarcoma. Atlas Genet Cytogenet Oncol Haematol 7:44–47
Carlson ML, O’Connell BP, Breen JT et al (2016) Petroclival chondrosarcoma: a multicenter review of 55 cases and new staging system. Otol Neurotol 37:940–950. https://doi.org/10.1097/MAO.0000000000001037
Casali PG, Bielack S, Abecassis N et al (2018) Bone sarcomas: ESMO-PaedCan-EURACAN clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 29:iv79–iv95. https://doi.org/10.1093/annonc/mdy310
Chang SY, Mok S, Park SC et al (2020) Treatment strategy for metastatic spinal tumors: a narrative review. Asian Spine J 14:513–525. https://doi.org/10.31616/asj.2020.0379
Chen X, Bahrami A, Pappo A et al (2014) Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma. Cell Rep 7:104–112. https://doi.org/10.1016/j.celrep.2014.03.003
Ciernik IF, Niemierko A, Harmon DC et al (2011) Proton-based radiotherapy for unresectable or incompletely resected osteosarcoma. Cancer 117:4522–4530. https://doi.org/10.1002/cncr.26037
Collins MT, de Castro LF, Boyce AM (2020) Denosumab for fibrous dysplasia: promising, but questions remain. J Clin Endocrinol Metab 105(11):e4179–e4180. https://doi.org/10.1210/clinem/dgaa091
Communications E Chordomas: Technologies, Techniques, and Treatment Strategies. Retrieved from https://medone-neurosurgery.thieme.com/ebooks/1761174#/ebook_1761174_SL69390943. Accessed on 21 Nov 2020
Conner JR, Hornick JL (2013) SATB2 is a novel marker of osteoblastic differentiation in bone and soft tissue tumours. Histopathology 63:36–49. https://doi.org/10.1111/his.12138
Dekutoski MB, Clarke MJ, Rose P et al (2016) Osteosarcoma of the spine: prognostic variables for local recurrence and overall survival, a multicenter ambispective study. J Neurosurg Spine 25:59–68. https://doi.org/10.3171/2015.11.SPINE15870
Di Maio S, Temkin N, Ramanathan D, Sekhar LN (2011) Current comprehensive management of cranial base chordomas: 10-year meta-analysis of observational studies. J Neurosurg 115:1094–1105. https://doi.org/10.3171/2011.7.JNS11355
Dominkus M, Ruggieri P, Bertoni F et al (2006) Histologically verified lung metastases in benign giant cell tumours–14 cases from a single institution. Int Orthop 30:499–504. https://doi.org/10.1007/s00264-006-0204-x
Feigenberg SJ, Marcus RB Jr, Zlotecki RA et al (2003) Radiation therapy for giant cell tumors of bone. Clin Orthop Relat Res 207–216. https://doi.org/10.1097/01.blo.0000069890.31220.b4
Fernandez-Miranda JC, Gardner PA, Snyderman CH et al (2014) Clival chordomas: a pathological, surgical, and radiotherapeutic review. Head Neck 36:892–906. https://doi.org/10.1002/hed.23415
Fisher CG, Keynan O, Boyd MC, Dvorak MF (2005) The surgical management of primary tumorsof the spine: initial results of an ongoing prospective cohort study. Spine (Phila Pa 1976) 30:1899–1908. https://doi.org/10.1097/01.brs.0000174114.90657.74
Fleming GF, Heimann PS, Stephens JK et al (1993) Dedifferentiated chordoma. Response to aggressive chemotherapy in two cases. Cancer 72:714–718. https://doi.org/10.1002/1097-0142(19930801)72:3%3c714::aid-cncr2820720314%3e3.0.co;2-1
Foweraker KL, Burton KE, Maynard SE et al (2007) High-dose radiotherapy in the management of chordoma and chondrosarcoma of the skull base and cervical spine: part 1–clinical outcomes. Clin Oncol (R Coll Radiol) 19:509–516. https://doi.org/10.1016/j.clon.2007.04.004
Freeman JL, Oushy S, Schowinsky J et al (2016) Invasive giant cell tumor of the lateral skull base: a systematic review, meta-analysis, and case illustration. World Neurosurg 96:47–57. https://doi.org/10.1016/j.wneu.2016.05.086
Fujino M (2018) The histopathology of myeloma in the bone marrow. J Clin Exp Hematop 58:61–67. https://doi.org/10.3960/jslrt.18014
Gamboa NT, Ronna B, Gamboa CT et al (2018) Giant cell tumor of the lateral skull base: diagnostic and management options. J Neurol Surg Rep 79:e41–e54. https://doi.org/10.1055/s-0038-1645885
Gay E, Sekhar LN, Rubinstein E et al (1995) Chordomas and chondrosarcomas of the cranial base: results and follow-up of 60 patients. Neurosurgery 36:887–896 (discussion 896–897). https://doi.org/10.1227/00006123-199505000-00001
Gilligan T, Kantoff PW (2002) Chemotherapy for prostate cancer. Urology 60:94–100 (discussion 100). https://doi.org/10.1016/s0090-4295(02)01583-2
González D, van der Burg M, García-Sanz R et al (2007) Immunoglobulin gene rearrangements and the pathogenesis of multiple myeloma. Blood 110:3112–3121. https://doi.org/10.1182/blood-2007-02-069625
Goorin AM, Perez-Atayde A, Gebhardt M et al (1987) Weekly high-dose methotrexate and doxorubicin for osteosarcoma: the Dana-Farber Cancer Institute/The Children’s Hospital–study III. J Clin Oncol 5:1178–1184. https://doi.org/10.1200/JCO.1987.5.8.1178
Gore MR, Zanation AM, Ebert CS, Senior BA (2011) Cholesterol granuloma of the petrous apex. Otolaryngol Clin North Am 44:1043–1058. https://doi.org/10.1016/j.otc.2011.06.005
Gounder MM, Zhu G, Roshal L et al (2019) Immunologic correlates of the abscopal effect in a SMARCB1/INI1-negative poorly differentiated chordoma after EZH2 inhibition and radiotherapy. Clin Cancer Res 25:2064–2071. https://doi.org/10.1158/1078-0432.CCR-18-3133
Grossman RI, Davis KR (1981) Cranial computed tomographic appearance of chondrosarcoma of the base of the skull. Radiology 141:403–408. https://doi.org/10.1148/radiology.141.2.7291563
Guo Z, Hu K, Zhao B et al (2017) Osteosarcoma of the skull base: an analysis of 19 cases and literature review. J Clin Neurosci 44:133–142. https://doi.org/10.1016/j.jocn.2017.06.014
Hakim DN, Pelly T, Kulendran M, Caris JA (2015) Benign tumours of the bone: a review. J Bone Oncol 4:37–41. https://doi.org/10.1016/j.jbo.2015.02.001
Harwick RD, Miller AS (1979) Craniocervical chordomas. Am J Surg 138:512–516. https://doi.org/10.1016/0002-9610(79)90410-0
Hasegawa H, Shin M, Kondo K et al (2018) Role of endoscopic transnasal surgery for skull base chondrosarcoma: a retrospective analysis of 19 cases at a single institution. J Neurosurg 128:1438–1447. https://doi.org/10.3171/2017.1.JNS162000
Hassounah M, Al-Mefty O, Akhtar M et al (1985) Primary cranial and intracranial chondrosarcoma: a survey. Acta Neurochir (Wien) 78:123–132. https://doi.org/10.1007/BF01808691
Healy CF, Murray JG, Eustace SJ et al (2011) Multiple myeloma: a review of imaging features and radiological techniques. Bone Marrow Res 2011:e583439. https://doi.org/10.1155/2011/583439
Heffelfinger MJ, Dahlin DC, MacCarty CS, Beabout JW (1973) Chordomas and cartilaginous tumors at the skull base. Cancer 32:410–420. https://doi.org/10.1002/1097-0142(197308)32:2%3c410::aid-cncr2820320219%3e3.0.co;2-s
Hoa M, House JW, Linthicum FH, Go JL (2013) Petrous apex cholesterol granuloma: pictorial review of radiological considerations in diagnosis and surgical histopathology. J Laryngol Otol 127:339–348. https://doi.org/10.1017/S0022215113000091
Holland J, Trenkner DA, Wasserman TH, Fineberg B (1992) Plasmacytoma. Treatment results and conversion to myeloma. Cancer 69:1513–1517. https://doi.org/10.1002/1097-0142(19920315)69:6%3c1513::aid-cncr2820690633%3e3.0.co;2-x
Hotta K, Takahashi H, Satoh N, Gojobori T (2008) Brachyury-downstream gene sets in a chordate, ciona intestinalis: integrating notochord specification, morphogenesis and chordate evolution. Evol Dev 10:37–51. https://doi.org/10.1111/j.1525-142X.2007.00212.x
Hsieh PC, Xu R, Sciubba DM et al (2009) Long-term clinical outcomes following en bloc resections for sacral chordomas and chondrosarcomas: a series of twenty consecutive patients. Spine (Phila Pa 1976) 34:2233–2239. https://doi.org/10.1097/BRS.0b013e3181b61b90
Hsieh PC, Gallia GL, Sciubba DM et al (2011) En bloc excisions of chordomas in the cervical spine: review of five consecutive cases with more than 4-year follow-up. Spine (Phila Pa 1976) 36:E1581–1587. https://doi.org/10.1097/BRS.0b013e318211839c
Hug EB, Loredo LN, Slater JD et al (1999) Proton radiation therapy for chordomas and chondrosarcomas of the skull base. J Neurosurg 91:432–439. https://doi.org/10.3171/jns.1999.91.3.0432
Huh A, Villelli N, Martinez D et al (2018) Denosumab treatment for a residual giant cell tumor of the clivus: a case report and review of the literature. World Neurosurg 118:98–101. https://doi.org/10.1016/j.wneu.2018.06.242
Inoue A, Ohnishi T, Kohno S et al (2016) Role of denosumab in endoscopic endonasal treatment for juvenile clival giant cell tumor: a case report and review of the literature. World Neurosurg 91:674.e1–6. https://doi.org/10.1016/j.wneu.2016.04.054
Inwards CY, Unni KK (1995) Classification and grading of bone sarcomas. Hematol Oncol Clin North Am 9:545–569
Italiano A, Mir O, Cioffi A et al (2013) Advanced chondrosarcomas: role of chemotherapy and survival. Ann Oncol 24:2916–2922. https://doi.org/10.1093/annonc/mdt374
Jawad MU, Scully SP (2010) Surgery significantly improves survival in patients with chordoma. Spine (Phila Pa 1976) 35:117–123. https://doi.org/10.1097/BRS.0b013e3181b44387
Jo VY, Fletcher CDM (2014) WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition. Pathology 46:95–104. https://doi.org/10.1097/PAT.0000000000000050
Jour G, Oultache A, Sadowska J et al (2016) GNAS mutations in fibrous dysplasia: a comparative study of standard sequencing and locked nucleic acid PCR sequencing on decalcified and non-decalcified formalin fixed paraffin embedded tissues. Appl Immunohistochem Mol Morphol 24:660–667. https://doi.org/10.1097/PAI.0000000000000242
Kanamori H, Kitamura Y, Kimura T et al (2015) Genetic characterization of skull base chondrosarcomas. J Neurosurg 123:1036–1041. https://doi.org/10.3171/2014.12.JNS142059
Kanazawa R, Yoshida D, Takahashi H et al (2003) Osteosarcoma arising from the skull–case report. Neurol Med Chir (Tokyo) 43:88–91. https://doi.org/10.2176/nmc.43.88
Kano H, Sheehan J, Sneed PK et al (2015) Skull base chondrosarcoma radiosurgery: report of the North American Gamma Knife Consortium. J Neurosurg 123:1268–1275. https://doi.org/10.3171/2014.12.JNS132580
Katonis P, Datsis G, Karantanas A et al (2013) Spinal osteosarcoma. Clin Med Insights Oncol 7:199–208. https://doi.org/10.4137/CMO.S10099
Komotar RJ, Starke RM, Raper DMS et al (2011) The endoscope-assisted ventral approach compared with open microscope-assisted surgery for clival chordomas. World Neurosurg 76:318–327 (discussion 259–262). https://doi.org/10.1016/j.wneu.2011.02.026
Korten AG, ter Berg HJ, Spincemaille GH et al (1998) Intracranial chondrosarcoma: review of the literature and report of 15 cases. J Neurol Neurosurg Psychiatry 65:88–92. https://doi.org/10.1136/jnnp.65.1.88
Koutourousiou M, Snyderman CH, Fernandez-Miranda J, Gardner PA (2011) Skull base chordomas. Otolaryngol Clin North Am 44:1155–1171. https://doi.org/10.1016/j.otc.2011.06.002
Kovac M, Blattmann C, Ribi S et al (2015) Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency. Nat Commun 6:8940. https://doi.org/10.1038/ncomms9940
Kuruma T, Tanigawa T, Uchida Y et al (2017) Large cholesterol granuloma of the middle ear eroding into the middle cranial fossa. Case Rep Otolaryngol 2017:4793786. https://doi.org/10.1155/2017/4793786
Kushchayeva YS, Kushchayev SV, Glushko TY et al (2018) Fibrous dysplasia for radiologists: beyond ground glass bone matrix. Insights Imaging 9:1035–1056. https://doi.org/10.1007/s13244-018-0666-6
Kwon JW, Chung HW, Cho EY et al (2007) MRI findings of giant cell tumors of the spine. AJR Am J Roentgenol 189:246–250. https://doi.org/10.2214/AJR.06.1472
Kyle RA, Gertz MA, Witzig TE et al (2003) Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc 78:21–33. https://doi.org/10.4065/78.1.21
Labidi M, Watanabe K, Bouazza S et al (2016) Clivus chordomas: a systematic review and meta-analysis of contemporary surgical management. J Neurosurg Sci 60:476–484
Larizza L, Mortini P, Riva P (2005) Update on the cytogenetics and molecular genetics of chordoma. Hered Cancer Clin Pract 3:29–41. https://doi.org/10.1186/1897-4287-3-1-29
Lau YS, Sabokbar A, Gibbons CLMH et al (2005) Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue. Hum Pathol 36:945–954. https://doi.org/10.1016/j.humpath.2005.07.005
Le LP, Nielsen GP, Rosenberg AE et al (2011) Recurrent chromosomal copy number alterations in sporadic chordomas. PLoS ONE 6:e18846. https://doi.org/10.1371/journal.pone.0018846
Lee J, FitzGibbon E, Chen Y et al (2012) Clinical guidelines for the management of craniofacial fibrous dysplasia. Orphanet J Rare Dis 7:S2. https://doi.org/10.1186/1750-1172-7-S1-S2
Leggon RE, Zlotecki R, Reith J, Scarborough MT (2004) Giant cell tumor of the pelvis and sacrum: 17 cases and analysis of the literature. Clin Orthop Relat Res 423:196 207. https://doi.org/10.1097/01.blo.0000128643.38390.07
Li G, Cai L, Zhou L (2019) Microarray gene expression profiling and bioinformatics analysis reveal key differentially expressed genes in clival and sacral chordoma cell lines. Neurol Res 41:554–561. https://doi.org/10.1080/01616412.2019.1582182
Lim CY, Liu X, He F et al (2020) Retrospective cohort study of 68 sacral giant cell tumours treated with nerve-sparing surgery and evaluation on therapeutic benefits of denosumab therapy. Bone Joint J 102-B:177–185. https://doi.org/10.1302/0301-620X.102B2.BJJ-2019-0813.R1
Link MP, Goorin AM, Horowitz M et al (1991) Adjuvant chemotherapy of high-grade osteosarcoma of the extremity. Updated results of the Multi-Institutional Osteosarcoma Study. Clin Orthop Relat Res 270:8–14
Littrell LA, Wenger DE, Wold LE et al (2004) Radiographic, CT, and MR imaging features of dedifferentiated chondrosarcomas: a retrospective review of 174 de novo cases. Radiographics 24:1397–1409. https://doi.org/10.1148/rg.245045009
Lo WW, Solti-Bohman LG, Brackmann DE, Gruskin P (1984) Cholesterol granuloma of the petrous apex: CT diagnosis. Radiology 153:705–711. https://doi.org/10.1148/radiology.153.3.6494466
Lustig LR, Holliday MJ, McCarthy EF, Nager GT (2001) Fibrous dysplasia involving the skull base and temporal bone. Arch Otolaryngol Head Neck Surg 127:1239–1247. https://doi.org/10.1001/archotol.127.10.1239
Mahale A, Dhananjaya KVN, Pai M et al (2013) MRI sequence and characteristic features in “giant cell tumor” of clivus. J Clin Diagn Res 7:1197–1200. https://doi.org/10.7860/JCDR/2013/2725.3021
Martin C, McCarthy EF (2010) Giant cell tumor of the sacrum and spine: series of 23 cases and a review of the literature. Iowa Orthop J 30:69–75
Martin E, Senders JT, Ter Wengel PV et al (2019) Treatment and survival of osteosarcoma and Ewing sarcoma of the skull: a SEER database analysis. Acta Neurochir (Wien) 161:317–325. https://doi.org/10.1007/s00701-018-3754-y
Masaany M, Siti HS, Nurliza I, Mazita A (2008) Bilateral middle ear cholesterol granuloma in familial hypercholesterolemia. Otolaryngol Head Neck Surg 138:803–804. https://doi.org/10.1016/j.otohns.2008.02.020
Matarazzo P, Lala R, Masi G et al (2002) Pamidronate treatment in bone fibrous dysplasia in children and adolescents with McCune-Albright syndrome. J Pediatr Endocrinol Metab 15(Suppl 3):929–937
McGrath PJ (1972) Giant-cell tumour of bone: an analysis of fifty-two cases. J Bone Joint Surg Br 54:216–229
Meis JM, Raymond AK, Evans HL et al (1987) “Dedifferentiated” chordoma. A clinicopathologic and immunohistochemical study of three cases. Am J Surg Pathol 11:516–525
Meyers PA, Schwartz CL, Krailo MD et al (2008) Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival–a report from the children’s oncology group. J Clin Oncol 26:633–638. https://doi.org/10.1200/JCO.2008.14.0095
Migliorini F, Maffulli N, Trivellas A et al (2020) Bone metastases: a comprehensive review of the literature. Mol Biol Rep 47:6337–6345. https://doi.org/10.1007/s11033-020-05684-0
Mitsuya K, Nakasu Y, Horiguchi S et al (2011) Metastatic skull tumors: MRI features and a new conventional classification. J Neurooncol 104:239–245. https://doi.org/10.1007/s11060-010-0465-5
Mohyeldin A, Prevedello DM, Jamshidi AO et al (2014) Nuances in the treatment of malignant tumors of the clival and petroclival region. Int Arch Otorhinolaryngol 18:S157-172. https://doi.org/10.1055/s-0034-1395267
Morgan T, Atkins GJ, Trivett MK et al (2005) Molecular profiling of giant cell tumor of bone and the osteoclastic localization of ligand for receptor activator of nuclear factor kappaB. Am J Pathol 167:117–128. https://doi.org/10.1016/s0002-9440(10)62959-8
Morgan GJ, Walker BA, Davies FE (2012) The genetic architecture of multiple myeloma. Nat Rev Cancer 12:335–348. https://doi.org/10.1038/nrc3257
Mosnier I, Cyna-Gorse F, Grayeli AB et al (2002) Management of cholesterol granulomas of the petrous apex based on clinical and radiologic evaluation. Otol Neurotol 23:522–528
Moussazadeh N, Kulwin C, Anand VK et al (2015) Endoscopic endonasal resection of skull base chondrosarcomas: technique and early results. J Neurosurg 122:735–742. https://doi.org/10.3171/2014.11.JNS14827
Na’ara S, Amit M, Gil Z, Billan S (2016) Plasmacytoma of the skull base: a meta-analysis. J Neurol Surg B Skull Base 77:61–65. https://doi.org/10.1055/s-0035-1560047
O’Neill P, Bell BA, Miller JD et al (1985) Fifty years of experience with chordomas in southeast Scotland. Neurosurgery 16:166–170. https://doi.org/10.1227/00006123-198502000-00007
Oghalai JS, Buxbaum JL, Jackler RK, McDermott MW (2005) Skull base chondrosarcoma originating from the petroclival junction. Otol Neurotol 26:1052–1060. https://doi.org/10.1097/01.mao.0000185076.65822.f7
Oot RF, Melville GE, New PF et al (1988) The role of MR and CT in evaluating clival chordomas and chondrosarcomas. AJR Am J Roentgenol 151:567–575. https://doi.org/10.2214/ajr.151.3.567
Ozaki T, Flege S, Liljenqvist U et al (2002) Osteosarcoma of the spine: experience of the cooperative osteosarcoma study group. Cancer 94:1069–1077
Palumbo A, Avet-Loiseau H, Oliva S et al (2015) Revised international staging system for multiple myeloma: a report from international myeloma working group. J Clin Oncol 33:2863–2869. https://doi.org/10.1200/JCO.2015.61.2267
Papapetrou C, Edwards YH, Sowden JC (1997) The T transcription factor functions as a dimer and exhibits a common human polymorphism Gly-177-Asp in the conserved DNA-binding domain. FEBS Lett 409:201–206. https://doi.org/10.1016/s0014-5793(97)00506-1
Park K, Bae GH, Kim WK et al (2021) Radiotherapy for brain metastasis and long-term survival. Sci Rep 11:8046. https://doi.org/10.1038/s41598-021-87357-x
Patel CR, Wang EW, Fernandez-Miranda JC et al (2018) Contralateral transmaxillary corridor: an augmented endoscopic approach to the petrous apex. J Neurosurg 129:211–219. https://doi.org/10.3171/2017.4.JNS162483
Patel CR, Snyderman CH, Fernandez-Miranda JC et al (2021) Mucosal grafting reduces recurrence after endonasal surgery of petrous apex cholesterol granulomas. Laryngoscope 131:E2513–E2517. https://doi.org/10.1002/lary.29432
Perry JA, Kiezun A, Tonzi P et al (2014) Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma. Proc Natl Acad Sci USA 111:E5564-5573. https://doi.org/10.1073/pnas.1419260111
Persson S, Kindblom LG, Angervall L (1991) Classical and chondroid chordoma. A light-microscopic, histochemical, ultrastructural and immunohistochemical analysis of the various cell types. Pathol Res Pract 187:828–838. https://doi.org/10.1016/S0344-0338(11)80579-0
Pillay N, Plagnol V, Tarpey PS et al (2012) A common single-nucleotide variant in T is strongly associated with chordoma. Nat Genet 44:1185–1187. https://doi.org/10.1038/ng.2419
Podliashchuk EL, Rozenblium EM, Rostovtseva TF (1985) Late results and consequences of radiotherapy of fibrous dysplasia of the skull. Med Radiol (Mosk) 30:9–12
Qu N, Yao W, Cui X, Zhang H (2015) Malignant transformation in monostotic fibrous dysplasia: clinical features, imaging features, outcomes in 10 patients, and review. Medicine (Baltimore) 94:e369. https://doi.org/10.1097/MD.0000000000000369
Raghavan D, Lee TC, Curtin HD (2015) Cholesterol granuloma of the petrous apex: a 5-year review of radiology reports with follow-up of progression and treatment. J Neurol Surg B Skull Base 76:266–271. https://doi.org/10.1055/s-0034-1396600
Ramachandran A, Inyang AF, Subhawong TK (2016) Apparent diffusion coefficient map of a case of extramedullary plasmacytoma. J Radiol Case Rep 10:10–16. https://doi.org/10.3941/jrcr.v10i2.2418
Raza SM, Gidley PW, Meis JM et al (2017) Multimodality treatment of skull base chondrosarcomas: the role of histology specific treatment protocols. Neurosurgery 81:520–530. https://doi.org/10.1093/neuros/nyx042
Raza SM, Habib A, Wang W-L et al (2020) Surgical management of primary skull base osteosarcomas: impact of margin status and patterns of relapse. Neurosurgery 86:E23–E32. https://doi.org/10.1093/neuros/nyz360
Reeskamp LF, Tromp TR, Defesche JC et al (2021) Next-generation sequencing to confirm clinical familial hypercholesterolemia. Eur J Prev Cardiol 28:875–883. https://doi.org/10.1093/eurjpc/zwaa451
Rendina D, Mossetti G, Soscia E et al (2004) Giant cell tumor and Paget’s disease of bone in one family: geographic clustering. Clin Orthop Relat Res 218–224. https://doi.org/10.1097/00000118702.46373.e3
Rickel K, Fang F, Tao J (2017) Molecular genetics of osteosarcoma. Bone 102:69–79. https://doi.org/10.1016/j.bone.2016.10.017
Riddle ND, Bui MM (2013) Fibrous dysplasia. Arch Pathol Lab Med 137:134–138. https://doi.org/10.5858/arpa.2012.0013-RS
Rosenberg AE, Nielsen GP, Keel SB et al (1999) Chondrosarcoma of the base of the skull: a clinicopathologic study of 200 cases with emphasis on its distinction from chordoma. Am J Surg Pathol 23:1370–1378. https://doi.org/10.1097/00000478-199911000-00007
Roussel M, Lauwers-Cances V, Robillard N et al (2014) Front-line transplantation program with lenalidomide, bortezomib, and dexamethasone combination as induction and consolidation followed by lenalidomide maintenance in patients with multiple myeloma: a phase II study by the Intergroupe Francophone du Myélome. J Clin Oncol 32:2712–2717. https://doi.org/10.1200/JCO.2013.54.8164
Ruggieri P, Mavrogenis AF, Ussia G et al (2010) Recurrence after and complications associated with adjuvant treatments for sacral giant cell tumor. Clin Orthop Relat Res 468:2954–2961. https://doi.org/10.1007/s11999-010-1448-8
Samii A, Gerganov V, Herold C, et al (2009) Surgical treatment of skull base chondrosarcomas. Neurosurg Rev 32:67–75 (discussion 75). https://doi.org/10.1007/s10143-008-0170-4
Sanjay BK, Sim FH, Unni KK et al (1993) Giant-cell tumours of the spine. J Bone Joint Surg Br 75:148–154. https://doi.org/10.1302/0301-620X.75B1.8421014
Savini R, Gherlinzoni F, Morandi M et al (1983) Surgical treatment of giant-cell tumor of the spine. The experience at the Istituto Ortopedico Rizzoli. J Bone Joint Surg Am 65:1283–1289
Scheil-Bertram S, Kappler R, von Baer A et al (2014) Molecular profiling of chordoma. Int J Oncol 44:1041–1055. https://doi.org/10.3892/ijo.2014.2268
Schoenfeld AJ, Hornicek FJ, Pedlow FX et al (2012) Chondrosarcoma of the mobile spine: a review of 21 cases treated at a single center. Spine (Phila Pa 1976) 37:119–126. https://doi.org/10.1097/BRS.0b013e31823d2143
Scimeca PG, James-Herry AG, Black KS et al (1996) Chemotherapeutic treatment of malignant chordoma in children. J Pediatr Hematol Oncol 18:237–240. https://doi.org/10.1097/00043426-199605000-00032
Sciubba DM, Petteys RJ, Dekutoski MB et al (2010) Diagnosis and management of metastatic spine disease: a review. J Neurosurg Spine 13:94–108. https://doi.org/10.3171/2010.3.SPINE09202
Scotto di Carlo F, Divisato G, Iacoangeli M et al (2018) The identification of H3F3A mutation in giant cell tumour of the clivus and the histological diagnostic algorithm of other clival lesions permit the differential diagnosis in this location. BMC Cancer 18:358. https://doi.org/10.1186/s12885-018-4291-z
Sekhar LN, Pranatartiharan R, Chanda A, Wright DC (2001) Chordomas and chondrosarcomas of the skull base: results and complications of surgical management. Neurosurg Focus 10:E2. https://doi.org/10.3171/foc.2001.10.3.3
Sharifnia T, Wawer MJ, Chen T et al (2019) Small-molecule targeting of brachyury transcription factor addiction in chordoma. Nat Med 25:292–300. https://doi.org/10.1038/s41591-018-0312-3
Shives TC, McLeod RA, Unni KK, Schray MF (1989) Chondrosarcoma of the spine. J Bone Joint Surg Am 71:1158–1165
Smeele LE, Snow GB, van der Waal I (1998) Osteosarcoma of the head and neck: meta-analysis of the nonrandomized studies. Laryngoscope 108:946. https://doi.org/10.1097/00005537-199806000-00030
Souhami RL, Craft AW, Van der Eijken JW et al (1997) Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup. Lancet 350:911–917. https://doi.org/10.1016/S0140-6736(97)02307-6
Stark AM, Eichmann T, Mehdorn HM (2003) Skull metastases: clinical features, differential diagnosis, and review of the literature. Surg Neurol 60:219–225. https://doi.org/10.1016/S0090-3019(03)00269-6
Stephens PJ, Greenman CD, Fu B et al (2011) Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 144:27–40. https://doi.org/10.1016/j.cell.2010.11.055
Szuhai K, Cleton-Jansen A-M, Hogendoorn PCW, Bovée JVMG (2012) Molecular pathology and its diagnostic use in bone tumors. Cancer Genet 205:193–204. https://doi.org/10.1016/j.cancergen.2012.04.001
Thomas D, Henshaw R, Skubitz K et al (2010) Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study. Lancet Oncol 11:275–280. https://doi.org/10.1016/S1470-2045(10)70010-3
Thumallapally N, Meshref A, Mousa M, Terjanian T (2017) Solitary plasmacytoma: population-based analysis of survival trends and effect of various treatment modalities in the USA. BMC Cancer 17:13. https://doi.org/10.1186/s12885-016-3015-5
Tosi P (2013) Diagnosis and treatment of bone disease in multiple myeloma: spotlight on spinal involvement. Scientifica (Cairo) 2013:104546. https://doi.org/10.1155/2013/104546
Tzortzidis F, Elahi F, Wright DC, et al (2006) Patient outcome at long-term follow-up after aggressive microsurgical resection of cranial base chondrosarcomas. Neurosurgery 58:1090–1098 (discussion 1090–1098). https://doi.org/10.1227/01.NEU.0000215892.65663.54
Venteicher AS, McDowell MM, Goldschmidt E et al (2020) A preoperative risk classifier that predicts tumor progression in patients with cranial base chondrosarcomas. J Neurosurg 1–9. https://doi.org/10.3171/2019.10.JNS191672
Walcott BP, Nahed BV, Mohyeldin A et al (2012) Chordoma: current concepts, management, and future directions. Lancet Oncol 13:e69-76. https://doi.org/10.1016/S1470-2045(11)70337-0
Walker BA, Leone PE, Chiecchio L et al (2010) A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value. Blood 116:e56-65. https://doi.org/10.1182/blood-2010-04-279596
Weng J-C, Li D, Wang L et al (2018) Surgical management and long-term outcomes of intracranial giant cell tumors: a single-institution experience with a systematic review. J Neurosurg 131:695–705. https://doi.org/10.3171/2018.4.JNS1849
Werner M (2006) Giant cell tumour of bone: morphological, biological and histogenetical aspects. Int Orthop 30:484–489. https://doi.org/10.1007/s00264-006-0215-7
Wold LE, Laws ER (1983) Cranial chordomas in children and young adults. J Neurosurg 59:1043–1047. https://doi.org/10.3171/jns.1983.59.6.1043
Xu W, Li X, Huang W et al (2013) Factors affecting prognosis of patients with giant cell tumors of the mobile spine: retrospective analysis of 102 patients in a single center. Ann Surg Oncol 20:804–810. https://doi.org/10.1245/s10434-012-2707-6
Yap FHX, Amanuel B, Van Vliet C et al (2021) Malignant transformation of fibrous dysplasia into osteosarcoma confirmed with TP53 somatic mutation and mutational analysis of GNAS gene. Pathology 53:652–654. https://doi.org/10.1016/j.pathol.2020.08.027
Zenonos GA, Fernandez-Miranda JC, Mukherjee D et al (2018) Prospective validation of a molecular prognostication panel for clival chordoma. J Neurosurg 1–10. https://doi.org/10.3171/2018.3.JNS172321
Zenonos GA, Wang EW, Tyler-Kabara EC et al (2016) Endoscopic endonasal surgery for clival chordomas. J Neurol Surg B Skull Base 77:FP-11–5–11. https://doi.org/10.1055/s-0036-1592493
Zhang Z, Xu J, Yao Y et al (2013) Giant cell tumors of the skull: a series of 18 cases and review of the literature. J Neurooncol 115:437–444. https://doi.org/10.1007/s11060-013-1242-z
Zhang K, Zhou M, Chen H et al (2015) Expression of IMP3 and IGF2 in giant cell tumor of spine is associated with tumor recurrence and angiogenesis. Clin Transl Oncol 17:570–575. https://doi.org/10.1007/s12094-015-1280-4
Ziu E, Viswanathan VK, Mesfin FB (2021) Spinal Metastasis. In: StatPearls. StatPearls Publishing, Treasure Island (FL)
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Gersey, Z.C., Zenonos, G.A., Gardner, P.A. (2023). Malignant Brain and Spinal Tumors Originating from Bone or Cartilage. In: Rezaei, N., Hanaei, S. (eds) Human Brain and Spinal Cord Tumors: From Bench to Bedside. Volume 2. Advances in Experimental Medicine and Biology, vol 1405. Springer, Cham. https://doi.org/10.1007/978-3-031-23705-8_18
Download citation
DOI: https://doi.org/10.1007/978-3-031-23705-8_18
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-23704-1
Online ISBN: 978-3-031-23705-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)